Óskare Capital
Overview
Óskare Capital is a venture capital firm that provides investors with professionally managed exposure to the European cannabis ecosystem.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Octarine Bio | Jan 2026 | Series A Extension | Co-investor |
| IASO Ltd | Nov 2022 | Seed | Co-investor |
| Herbolea Biotech S.p.A. | Oct 2021 | Series A | Lead |
| Prohibition Partners | Jan 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Óskare Capital based?
Óskare Capital is headquartered in Paris, France.
When was Óskare Capital founded?
Óskare Capital was founded in 2019.
How many portfolio companies does Óskare Capital have?
Óskare Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Óskare Capital's portfolio?
Portfolio companies visible on Caplight include Octarine Bio, IASO Ltd, Herbolea Biotech S.p.A., Prohibition Partners.
What was Óskare Capital's most recent investment shown here?
Óskare Capital's most recent investment in this portfolio sample was in Octarine Bio in 2026.
What sectors does Óskare Capital focus on?
Óskare Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Media, Entertainment & Gaming, Enterprise Software, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Óskare Capital focus on?
Óskare Capital typically invests at the Early stage.
What is Óskare Capital's AUM?
Óskare Capital's assets under management are estimated between $82.8M and $82.8M.